Your browser is no longer supported. Please, upgrade your browser.
EBS Emergent BioSolutions Inc. daily Stock Chart
EBS [NYSE]
Emergent BioSolutions Inc.
Index- P/E74.64 EPS (ttm)1.30 Insider Own3.30% Shs Outstand52.00M Perf Week8.04%
Market Cap5.08B Forward P/E19.48 EPS next Y4.96 Insider Trans-23.67% Shs Float44.49M Perf Month40.54%
Income68.10M PEG8.11 EPS next Q0.65 Inst Own89.40% Short Float6.02% Perf Quarter52.24%
Sales1.11B P/S4.59 EPS this Y-8.50% Inst Trans-0.04% Short Ratio4.26 Perf Half Y77.20%
Book/sh20.67 P/B4.68 EPS next Y20.20% ROA2.90% Target Price83.17 Perf Year122.00%
Cash/sh3.45 P/C28.00 EPS next 5Y9.20% ROE6.50% 52W Range39.11 - 97.10 Perf YTD79.17%
Dividend- P/FCF99.05 EPS past 5Y-2.60% ROI4.80% 52W High-0.45% Beta1.29
Dividend %- Quick Ratio1.80 Sales past 5Y22.30% Gross Margin62.20% 52W Low147.15% ATR4.23
Employees1834 Current Ratio3.00 Sales Q/Q1.00% Oper. Margin11.70% RSI (14)71.50 Volatility4.71% 4.18%
OptionableYes Debt/Eq0.73 EPS Q/Q52.70% Profit Margin6.10% Rel Volume0.81 Prev Close91.33
ShortableYes LT Debt/Eq0.71 EarningsApr 30 AMC Payout0.00% Avg Volume628.68K Price96.66
Recom1.70 SMA2021.18% SMA5019.87% SMA20053.32% Volume508,212 Change5.84%
Sep-12-19Initiated Guggenheim Buy
Sep-04-19Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18Upgrade Goldman Neutral → Buy
Aug-03-18Reiterated Chardan Capital Markets Buy $53 → $57
Jun-13-18Initiated Argus Buy $62
Apr-25-18Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18Initiated Goldman Neutral
Jan-16-18Reiterated Chardan Capital Markets Buy $47 → $53
Jun-28-16Reiterated Singular Research Buy $44 → $40
Apr-15-16Initiated Chardan Capital Markets Buy $47
Mar-28-16Initiated Singular Research Buy $44
Feb-19-16Initiated Wells Fargo Outperform
May-15-14Initiated Summer Street Research Buy $35
May-31-11Reiterated WBB Securities Strong Buy $20.50 → $30
Jan-10-11Reiterated Wedbush Outperform $27 → $32
Nov-05-10Reiterated Wedbush Outperform $22 → $27
Aug-18-10Upgrade WBB Securities Buy → Strong Buy $20.50
Aug-06-10Reiterated Caris & Company Buy $25 → $23
Jul-14-10Upgrade WBB Securities Hold → Buy $15.60 → $20.50
May-06-10Downgrade WBB Securities Buy → Hold $15.60
Jul-10-20 05:50PM  
11:30AM  
Jul-09-20 12:36PM  
Jul-08-20 11:25AM  
11:11AM  
09:00AM  
08:11AM  
Jul-07-20 11:46AM  
11:02AM  
06:00AM  
Jul-06-20 07:56AM  
06:52AM  
06:51AM  
06:30AM  
Jul-05-20 06:27AM  
Jul-04-20 10:25AM  
Jul-03-20 12:36PM  
Jul-02-20 08:55AM  
08:41AM  
Jul-01-20 06:15AM  
Jun-29-20 02:06PM  
12:45PM  
11:44AM  
09:12AM  
Jun-26-20 11:48AM  
Jun-25-20 07:00AM  
Jun-24-20 03:20PM  
10:12AM  
Jun-23-20 10:34AM  
Jun-22-20 08:22AM  
Jun-18-20 09:13AM  
08:34AM  
06:30AM  
Jun-16-20 04:05PM  
Jun-13-20 07:33AM  
Jun-12-20 08:51AM  
08:36AM  
Jun-11-20 02:34PM  
12:45PM  
12:00PM  
10:54AM  
09:06AM  
09:03AM  
08:48AM  
Jun-08-20 04:14PM  
11:33AM  
11:22AM  
Jun-07-20 06:57AM  
03:36AM  
Jun-05-20 07:39PM  
Jun-03-20 01:42PM  
Jun-01-20 09:34AM  
07:50AM  
06:30AM  
May-30-20 11:31AM  
May-26-20 12:05PM  
May-21-20 11:19AM  
May-18-20 05:28PM  
May-17-20 09:31AM  
May-16-20 09:04AM  
07:33AM  
May-14-20 11:51AM  
May-12-20 06:00AM  
May-07-20 11:14AM  
10:22AM  
09:20AM  
May-05-20 08:10AM  
May-04-20 01:21PM  
May-01-20 04:01AM  
Apr-30-20 06:35PM  
04:08PM  
Apr-29-20 12:47PM  
08:48AM  
Apr-24-20 04:21PM  
09:57AM  
08:37AM  
08:32AM  
Apr-23-20 11:00PM  
06:51PM  
12:32PM  
Apr-22-20 11:19AM  
Apr-21-20 04:55PM  
Apr-19-20 08:34AM  
Apr-17-20 02:25PM  
06:00AM  
Apr-16-20 06:30AM  
Apr-14-20 03:08AM  
Apr-08-20 06:00AM  
Apr-06-20 06:30AM  
Apr-05-20 06:10PM  
Apr-03-20 02:26PM  
12:54PM  
07:36AM  
Apr-02-20 04:05PM  
02:51PM  
Apr-01-20 09:42AM  
06:10AM  
Mar-31-20 05:35PM  
04:05PM  
Mar-29-20 07:04PM  
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin; and Trobigard a combination drug-device auto injector product candidate. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; CHIKUNGUNYA, a chikungunya virus-like particle vaccine; and ADENOVIRUS 4/7. Further, the company offers other discovery and preclinical product candidates addressing PHTs, including viral hemorrhagic fevers caused by Ebola, Marburg, Sudan, and Lassa viruses; diarrheal disease caused by Shigella; and heat-labile toxin producing enterotoxigenic Escherichia coli, etc. Additionally, it offers FLU-IGIV to treat Influenza A infection; and ZIKV-IG, a prophylaxis for Zika infections, as well as contract development and manufacturing services to pharma and biotech industries, and government agencies/non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Richard RonaldDirectorJun 03Sale87.516,572575,1424,269Jun 05 04:36 PM
Bailey SueDirectorJun 03Sale87.505,322465,69137,260Jun 05 04:33 PM
Hauer Jerome MDirectorMay 26Sale85.154,385373,37310,188May 27 05:10 PM
Zoon Kathryn CDirectorMay 26Sale85.104,093348,32213,489May 27 05:07 PM
Harsanyi ZsoltDirectorMay 14Option Exercise18.643,43464,01028,367May 18 07:12 PM
Zoon Kathryn CDirectorMay 12Sale85.211,660141,45414,761May 14 04:30 PM
Harsanyi ZsoltDirectorMay 11Sale81.994,940405,02524,933May 13 07:47 PM
JOULWAN GEORGE ADirectorMay 11Sale85.192,000170,37129,950May 13 07:45 PM
Richard RonaldDirectorMay 05Sale80.198,375671,6298,020May 06 05:08 PM
El-Hibri FuadChairmanApr 30Sale74.0120,0001,480,2001,229,523May 01 08:13 PM
El-Hibri FuadChairmanApr 29Sale74.2420,0001,484,8001,249,523May 01 08:13 PM
Richard RonaldDirectorApr 27Option Exercise20.087,893158,49124,288Apr 29 04:35 PM
Richard RonaldDirectorApr 27Sale78.007,893615,65416,395Apr 29 04:35 PM
El-Hibri FuadChairmanApr 23Sale68.4920,0001,369,8001,269,523Apr 24 04:16 PM
El-Hibri FuadChairmanApr 22Sale66.8120,0001,336,2001,289,523Apr 24 04:16 PM
Havey AdamEVP, Business OperationsApr 20Option Exercise30.8617,009524,89851,265Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 20Sale69.0017,0091,173,62134,256Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 17Option Exercise26.4520,414539,95054,670Apr 21 06:12 PM
Havey AdamEVP, Business OperationsApr 17Sale65.0020,4141,326,91034,256Apr 21 06:12 PM
El-Hibri FuadChairmanApr 16Sale62.4720,0001,249,4001,309,523Apr 20 06:30 PM
El-Hibri FuadChairmanApr 15Sale62.5812,537784,5651,329,523Apr 15 09:04 PM
El-Hibri FuadChairmanApr 14Sale62.996,261394,3801,342,060Apr 15 09:04 PM
El-Hibri FuadChairmanApr 13Sale62.2517,0711,062,6701,348,321Apr 15 09:04 PM
El-Hibri FuadChairmanApr 09Sale61.8323,7161,466,3601,365,392Apr 10 07:13 PM
El-Hibri FuadChairmanApr 08Sale61.1337,3622,284,1151,389,108Apr 10 07:13 PM
El-Hibri FuadChairmanApr 07Sale60.7614,336871,0551,426,470Apr 08 09:17 PM
Kirk SeanEVP, Manufacturing & Tech OpsApr 06Option Exercise30.7010,428320,13119,864Apr 08 08:19 PM
El-Hibri FuadChairmanApr 06Sale60.5028,2401,708,5201,440,806Apr 08 09:17 PM
Havey AdamEVP, Business OperationsApr 06Sale60.007,972478,32034,256Apr 08 08:22 PM
Kirk SeanEVP, Manufacturing & Tech OpsApr 06Sale60.0016,094965,64012,571Apr 08 08:19 PM
Harsanyi ZsoltDirectorMar 16Sale65.006,400416,00029,873Mar 17 04:39 PM
SULLIVAN LOUIS WDirectorMar 04Option Exercise13.8615,786218,71568,359Mar 06 04:37 PM
Zoon Kathryn CDirectorMar 04Sale60.6599160,10316,421Mar 06 04:39 PM
SULLIVAN LOUIS WDirectorMar 04Sale58.9615,786930,71460,466Mar 06 04:37 PM
El-Hibri FuadChairmanFeb 27Sale56.979,837560,4141,469,046Feb 28 08:01 PM
Bailey SueDirectorFeb 27Sale56.936,572374,13239,761Mar 02 05:28 PM
El-Hibri FuadChairmanFeb 26Sale58.7013,619799,4351,472,943Feb 28 08:01 PM
El-Hibri FuadChairmanFeb 21Option Exercise25.6218,567475,6871,497,585Feb 24 08:00 PM
Richard RonaldDirectorFeb 21Option Exercise18.645,15296,03331,851Feb 25 04:30 PM
Hauer Jerome MDirectorFeb 21Sale70.006,572460,04011,752Feb 25 04:28 PM
El-Hibri FuadChairmanFeb 21Sale64.9018,5671,204,9981,479,018Feb 24 08:00 PM
Richard RonaldDirectorFeb 21Sale65.005,152334,88016,395Feb 25 04:30 PM
El-Hibri FuadChairmanFeb 20Option Exercise25.624,751121,7211,483,769Feb 24 08:00 PM
El-Hibri FuadChairmanFeb 20Sale64.904,751308,3401,479,018Feb 24 08:00 PM
El-Hibri FuadChairmanFeb 18Option Exercise25.6215,614400,0311,494,632Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 18Sale63.9015,614997,7351,479,018Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 14Option Exercise25.624,386112,3691,483,404Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 14Sale63.904,386280,2651,479,018Feb 19 09:00 PM
El-Hibri FuadChairmanFeb 12Option Exercise25.6213,720351,5061,492,738Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 12Sale62.9013,720862,9881,479,018Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 11Option Exercise25.626,280160,8941,485,298Feb 13 06:30 PM
El-Hibri FuadChairmanFeb 11Sale62.906,280395,0121,479,018Feb 13 06:30 PM
El-Hibri FuadExecutive ChairmanFeb 06Sale61.9011,684723,2401,419,018Feb 07 06:31 PM
El-Hibri FuadExecutive ChairmanFeb 05Sale60.6648,3162,930,8491,430,702Feb 07 06:31 PM
Harsanyi ZsoltDirectorJan 16Sale55.003,435188,92536,273Jan 17 04:19 PM
Bailey SueDirectorDec 12Sale53.468,375447,72846,333Dec 13 09:21 AM
Zoon Kathryn CDirectorNov 18Sale54.311,00054,31417,412Nov 19 04:11 PM
Zoon Kathryn CDirectorNov 08Sale54.153,082166,88418,412Nov 12 09:52 AM
Richard RonaldDirectorNov 07Option Exercise18.645,15396,05231,852Nov 12 09:51 AM
Richard RonaldDirectorNov 07Sale60.005,153309,18026,699Nov 12 09:51 AM
Zoon Kathryn CDirectorSep 09Sale56.121,50984,69221,494Sep 10 05:44 PM